Tetrabenazine for the Treatment of Hyperkinetic Movement Disorders: A Review of the Literature - Chen, Jack J.; Ondo, William G.; Dashtipour, Khashayar; Swope, David M. (Clinical therapeutics, 2012)
Keywords: Adrenergic Uptake Inhibitors - adverse effects; Adrenergic Uptake Inhibitors - pharmacology; Adrenergic Uptake Inhibitors - therapeutic use; Adult and adolescent clinical studies; Animals; Biological and medical sciences; Chorea - drug therapy; Chorea - physiopathology; Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases; Dopamine; Drug dosages; dystonia; Dystonia - drug therapy; Dystonia - physiopathology; Humans; Huntington disease; Huntington Disease - drug therapy; Huntington Disease - physiopathology; Hyperkinesis - drug therapy; Hyperkinesis - physiopathology; Internal Medicine; Literature reviews; Medical Education; Medical sciences; Metabolites; Movement Disorders - drug therapy; Movement Disorders - physiopathology; Nervous system (semeiology, syndromes); Nervous system as a whole; Neurology; Organic mental disorders. Neuropsychology; Parkinson's disease; Pediatrics; Pharmacology. Drug treatments; Psychology. Psychoanalysis. Psychiatry; Psychopathology. Psychiatry; Rare Diseases - drug therapy; Rare Diseases - physiopathology; Studies; tardive dyskinesia; tetrabenazine; Tetrabenazine - adverse effects; Tetrabenazine - pharmacology; Tetrabenazine - therapeutic use; Text editing; Tic Disorders - drug therapy; Tic Disorders - physiopathology; tics; Tourette syndrome; United States--US; tetrabenazine; tics; dystonia; Huntington disease; tardive dyskinesia; Neuroleptic; Psychotropic; Involuntary movement; s: dystonia; Hyperkinesia; Degenerative disease; Neurological disorder; Dyskinesia; Nervous system diseases; Late; Tetrabenazine; Motor control; Genetic disease; Cerebral disorder; Tic; Striated muscle disease; Treatment; Central nervous system disease; Dystonia; Psychomotor disorder; Bibliographic review; Extrapyramidal syndrome